Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (33)
  • 2024 (40)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)
  • 2014 (0)

Subject

  • Drug Trafficking (1116)
  • Synthetic drugs (374)
  • Guns/Weapons (285)
  • OCDETF/Task Force (196)
  • Seizures (Drugs/Property) (176)
  • Guilty Plea (160)
  • Fake Pills (112)
  • Arrests/Convictions - Major (108)
  • Task Forces/Task Force Officers (105)
  • Overdose (100)
  • Major Law Enforcement Operation (91)
  • Prescription Drugs (84)
  • Pharmaceuticals/Pharmacists/Physicians (65)
  • Outreach/Drug Prevention (48)
  • Gangs (46)
  • Money Laundering (40)
  • Take Back Day (39)
  • HIDTA (30)
  • Press Conferences (25)
  • Public and Media Affairs - also see Congressional Affairs (24)
  • Prevention/Education - DEA websites GSAD, JTT etc (18)
  • Narcoterrorism (16)
  • Extraditions (11)
  • Dark Web- Internet Trafficking (7)
  • International/Foreign Operations (7)
  • Asset Forfeiture (6)
  • Fentanyl Awareness (6)
  • One Pill Can Kill (4)
  • Intergovernmental Affairs (3)
  • Museum and Visitors Center (3)
  • Red Ribbon (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Terrorism (1)
  • Diversion Division (54)

Drug Name

  • Opioids (11)
  • Oxycodone (10)
  • Fentanyl (8)
  • Hydromorphone (5)
  • Morphine (2)
  • Synthetic Opioids (2)
  • Amphetamines (1)
  • Benzodiazepines (1)
  • Methadone (1)
  • Steroids (1)

Field Division

  • New England (9)
  • Washington, DC (9)
  • New York (7)
  • New Jersey (6)
  • Chicago (5)
  • Seattle (5)
  • El Paso (4)
  • Atlanta (2)
  • Miami (2)
  • Dallas (1)
  • Omaha (1)
  • Phoenix (1)
  • San Diego (1)
  • San Francisco (1)
Clear All Results
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

Diciembre 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
Diciembre 29, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

Long Island Medical Doctor Charged with Illegally Distributing Oxycodone Pills

Diciembre 14, 2022
BROOKLYN, N.Y. – Late yesterday, in federal court in Central Islip, an 18-count indictment was returned charging Dr. Roya Jafari-Hassad with illegal distribution of oxycodone and witness tampering. Hassad was arrested this morning and is scheduled to be arraigned this afternoon before United States Magistrate Judge Steven L. Tiscione. Breon...
Diciembre 14, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

Diciembre 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
Diciembre 09, 2022
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

Diciembre 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
Diciembre 07, 2022
PRESS RELEASE

Arizona Communities Team up with DEA & Partners Turning in 4 Tons of Unneeded Prescription Medications

Noviembre 17, 2022
PHOENIX – On Oct. 29, 2022, communities across the country demonstrated their continued support for DEA’s bi-annual National Prescription Drug Take Back Day by safely disposing of more than 647,000 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s National Prescription...
Noviembre 17, 2022
PRESS RELEASE

Merced County Doctor Indicted for Multimillion Dollar Disability Insurance Fraud Scheme, Money Laundering, and Unrelated Drug Charges

Octubre 27, 2022
FRESNO, Calif. — On Oct. 20, 2022, a federal grand jury charged Sohail Mamdani, 46, of Los Banos, with mail fraud and money laundering in connection to a disability insurance fraud scheme, and unlawful use of a DEA registration number and fraudulently obtaining possession of a controlled substance, U.S. Attorney...
Octubre 27, 2022
PRESS RELEASE

Yale Agrees To Pay $308K To Resolve Allegations Of Violations Of Controlled Substances Act

Octubre 06, 2022
ORANGE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, today announced that Yale University, on behalf of Yale Medicine and the Yale Fertility Center, has entered into a civil settlement agreement with the federal government in which it will pay a total of $308,250 to...
Octubre 06, 2022
PRESS RELEASE

Oswego County Dentist Agrees to Pay $60,000 and Surrenders DEA Registration for Five Years Due to Office Staff’s Illegal Use of Electronic Prescription System

Octubre 03, 2022
SYRACUSE, NEW YORK – Dr. Omar Guesmia, of Phoenix, New York will pay $60,000 to resolve allegations that he, and his dentistry practice, “Gentle Dental Care,” violated the Controlled Substances Act by enabling an office staff member to use an electronic prescription system to obtain oxycodone for their own use...
Octubre 03, 2022
PRESS RELEASE

Company Pays $158,760 to Resolve Claims Related to Controlled Substance Thefts From Pharmacies During Inventory

Septiembre 30, 2022
ALBANY, NEW YORK – RGIS LLC (RGIS) and its affiliated company, Retail Services WIS Corporation (WIS), agreed to pay $158,760 to resolve allegations that they caused violations of the Controlled Substances Act. RGIS and WIS employees were implicated in the theft of controlled substances from pharmacies in upstate New York...
Septiembre 30, 2022
Showing 1 - 10 of 54 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster